ESGCT 29th Congress in collaboration with BSGCT
The 29th ESGCT (European Society of Gene and Cell Therapy) Annual Congress, bringing together leading researchers and key thought leaders in gene and cell therapy fields from Europe and around the globe, will be held in Edinburgh, Scotland from the 11th to 14th of October, 2022.
TransCure bioServices is honored to be attending this year’s Congress and pleased to be presenting our poster.
We look forward to participating in this exciting event, meeting with current and prospective partners, and learning about the latest advances in gene and cell therapy.
The Edinburgh International Conference Centre (EICC) is a state-of-the-art venue centrally situated in Scotland’s vibrant and historic capital city. You can access the event program here. We hope you’ll join us.
Attending in person for TransCure bioServices:
Clothilde Philouze, PhD, R&D Project Leader
After a PhD in Physiology at the University of Avignon, Clothilde pursued with 3 years of post-doc in the In-Vivo Pharmacology department at Servier Research Institute. Her research focused on ultrasound imaging and cardiovascular & metabolic diseases. She is now a Project Leader in the R&D department of TransCure bioServices, where she aims at developing new mouse models.